Business Today
Loading...

Strides Pharma to conduct clinical trials for potential coronavirus drug favipiravir

Shares of the company rose as much as 5.3% to a two-week high in early trade, and were last up 3.5% at 0408 GMT

twitter-logoReuters Last Updated: May 21, 2020 | 10:54 IST
Strides Pharma to conduct clinical trials for potential coronavirus drug favipiravir

Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has obtained regulatory approval to conduct clinical trials of antiviral drug favipiravir, a potential treatment for COVID-19.

The company has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country, Strides Founder and Non-Executive Chairman Arun Kumar said on a post-earnings conference call.

Shares of the company rose as much as 5.3% to a two-week high in early trade, and were last up 3.5% at 0408 GMT.

Also read: Coronavirus update: Bangladesh doctors say effective drug combination found

Also read: Lockdown 4.0 Coronavirus Live Updates: Aviation ministry issues SoPs for airports; India's cases-1.12 lakh

Youtube
  • Print

  • COMMENT
BT-Story-Page-B.gif
A    A   A
close